Precision medicine for primary rectal cancer will become a reality.
作者信息
Park In Ja
机构信息
Department of Colon and Rectal Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
出版信息
Ann Coloproctol. 2022 Aug;38(4):281-282. doi: 10.3393/ac.2022.00500.0071. Epub 2022 Aug 29.
Abstract
摘要
相似文献
1
Precision medicine for primary rectal cancer will become a reality.原发性直肠癌的精准医疗将成为现实。
Ann Coloproctol. 2022 Aug;38(4):281-282. doi: 10.3393/ac.2022.00500.0071. Epub 2022 Aug 29.
2
[Give attention to both minimally invasive surgery and precision medicine to promote the scientificality on individualized clinical practice of rectal cancer].兼顾微创外科与精准医学，提升直肠癌个体化临床实践科学性
Zhonghua Wai Ke Za Zhi. 2016 Jun 1;54(6):404-407. doi: 10.3760/cma.j.issn.0529-5815.2016.06.002.
3
Precision Diabetes Is Slowly Becoming a Reality.精准糖尿病治疗正逐渐成为现实。
Med Princ Pract. 2019;28(1):1-9. doi: 10.1159/000497241. Epub 2019 Jan 27.
4
Precision medicine in breast cancer: reality or utopia?乳腺癌的精准医学：现实还是乌托邦？
J Transl Med. 2017 Jun 17;15(1):139. doi: 10.1186/s12967-017-1239-z.
5
Organoids as Oracles for Precision Medicine in Rectal Cancer.类器官作为直肠癌精准医学的“先知”
Cell Stem Cell. 2020 Jan 2;26(1):4-6. doi: 10.1016/j.stem.2019.12.003.
6
A bioinformatics approach for precision medicine off-label drug drug selection among triple negative breast cancer patients.一种用于三阴性乳腺癌患者精准医学中选择超说明书用药的生物信息学方法。
J Am Med Inform Assoc. 2016 Jul;23(4):741-9. doi: 10.1093/jamia/ocw004. Epub 2016 Apr 23.
7
Precision medicine becomes reality-tumor type-agnostic therapy.精准医疗成为现实——肿瘤类型不可知的治疗方法。
Cancer Commun (Lond). 2018 Mar 31;38(1):6. doi: 10.1186/s40880-018-0274-3.
8
Early Lessons from the Implementation of Genomic Medicine Programs.基因组医学计划实施的早期经验教训。
Annu Rev Genomics Hum Genet. 2019 Aug 31;20:389-411. doi: 10.1146/annurev-genom-083118-014924. Epub 2019 Feb 27.
9
Virtual reality in surgery and medicine.外科手术与医学中的虚拟现实
Hosp Technol Ser. 1994;13(18):1-48.
10
Insights into the theranostic value of precision medicine on advanced radiotherapy to breast cancer.精准医学对晚期乳腺癌放射治疗的治疗价值的深入了解。
Int J Med Sci. 2021 Jan 1;18(3):626-638. doi: 10.7150/ijms.49544. eCollection 2021.
引用本文的文献
1
How Can We Improve the Tumor Response to Preoperative Chemoradiotherapy for Locally Advanced Rectal Cancer?我们如何提高局部晚期直肠癌对术前放化疗的肿瘤反应？
Ewha Med J. 2023 Dec;46(Suppl 1):e25. doi: 10.12771/emj.2023.e25. Epub 2023 Dec 31.
2
Inflammatory Response Markers as Predictors of Colorectal Cancer Prognosis.炎症反应标志物作为结直肠癌预后的预测指标
Ewha Med J. 2023 Dec;46(Suppl 1):e24. doi: 10.12771/emj.2023.e24. Epub 2023 Dec 31.
3
Influence of the COVID-19 Pandemic on the Treatment Patterns and Outcomes of Colorectal Cancer.2019年冠状病毒病大流行对结直肠癌治疗模式及治疗结果的影响
Ewha Med J. 2023 Dec;46(Suppl 1):e28. doi: 10.12771/emj.2023.e28. Epub 2023 Dec 31.
4
Preventing Anastomotic Leakage, a Devastating Complication of Colorectal Surgery.预防吻合口漏，结直肠手术的一种毁灭性并发症。
Ewha Med J. 2023 Dec;46(Suppl 1):e29. doi: 10.12771/emj.2023.e29. Epub 2023 Dec 31.
5
Beyond survival: a comprehensive review of quality of life in rectal cancer patients.超越生存：直肠癌患者生活质量的全面综述
Ann Coloproctol. 2024 Dec;40(6):527-537. doi: 10.3393/ac.2024.00745.0106. Epub 2024 Dec 20.
6
Performance reporting design in artificial intelligence studies using image-based TNM staging and prognostic parameters in rectal cancer: a systematic review.基于图像的TNM分期和直肠癌预后参数的人工智能研究中的性能报告设计：一项系统综述
Ann Coloproctol. 2024 Feb;40(1):13-26. doi: 10.3393/ac.2023.00892.0127. Epub 2024 Feb 28.
7
Unveiling the profound advantages of total neoadjuvant therapy in rectal cancer: a trailblazing exploration.揭示全新辅助治疗在直肠癌中的深远优势：一次开创性探索。
Ann Surg Treat Res. 2023 Dec;105(6):341-352. doi: 10.4174/astr.2023.105.6.341. Epub 2023 Nov 29.
本文引用的文献
1
PD-1 Blockade in Mismatch Repair-Deficient, Locally Advanced Rectal Cancer.PD-1 阻断在错配修复缺陷、局部晚期直肠癌中的应用。
N Engl J Med. 2022 Jun 23;386(25):2363-2376. doi: 10.1056/NEJMoa2201445. Epub 2022 Jun 5.
2
Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal Cancer.帕博利珠单抗治疗微卫星高度不稳定型晚期结直肠癌。
N Engl J Med. 2020 Dec 3;383(23):2207-2218. doi: 10.1056/NEJMoa2017699.
3
Early and Late Functional Outcomes of Anal Sphincter-Sparing Procedures With Total Mesorectal Excision for Anorectal Adenocarcinoma.保留肛门括约肌的全直肠系膜切除术治疗直肠腺癌的早期和晚期功能结局
Ann Coloproctol. 2020 Jul;36(3):148-154. doi: 10.3393/ac.2018.07.19. Epub 2020 Apr 20.
4
Mismatch Repair-Deficient Rectal Cancer and Resistance to Neoadjuvant Chemotherapy.错配修复缺陷型直肠癌与新辅助化疗耐药。
Clin Cancer Res. 2020 Jul 1;26(13):3271-3279. doi: 10.1158/1078-0432.CCR-19-3728. Epub 2020 Mar 6.
5
Current Status of "Watch-and-Wait" Rectal Cancer Treatment in Asia-Pacific Countries.亚太国家直肠癌“观察等待”治疗的现状
Ann Coloproctol. 2020 Apr;36(2):70-77. doi: 10.3393/ac.2020.01.19. Epub 2020 Jan 31.
6
Survival Contradiction Between Stage IIA and Stage IIIA Rectal Cancer: A Retrospective Study.IIA期与IIIA期直肠癌的生存矛盾：一项回顾性研究
J Cancer. 2018 Apr 6;9(8):1466-1475. doi: 10.7150/jca.23311. eCollection 2018.
7
Revised tumor and node categorization for rectal cancer based on surveillance, epidemiology, and end results and rectal pooled analysis outcomes.基于监测、流行病学和最终结果以及直肠汇总分析结果修订的直肠癌肿瘤和淋巴结分类。
J Clin Oncol. 2010 Jan 10;28(2):256-63. doi: 10.1200/JCO.2009.23.9194. Epub 2009 Nov 30.
Zotero 插件